Industry / innovation partners

The Transplant Is Not the Finish Line

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress

Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach

Bird Flu Reached NSW. Biosecurity Is On Trial.

Deep learning uncovers a new ECG biomarker for sudden cardiac death

Half of CKM patients go untreated and most fail control

Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice

The GLP-1 boom still needs exercise policy

In Australia, Cancer Medicine Delays Cost More Than Time
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
